Anti-IL17 Secukinumab in hidradenitis suppurativa: A long-term drug survival analysis.
Exp Dermatol
; 33(7): e15140, 2024 Jul.
Article
in En
| MEDLINE
| ID: mdl-39032087
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hidradenitis Suppurativa
/
Interleukin-17
/
Antibodies, Monoclonal, Humanized
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Exp Dermatol
Journal subject:
DERMATOLOGIA
Year:
2024
Document type:
Article
Affiliation country:
Italy
Country of publication:
Denmark